Taysha Gene Therapies, Inc. Increase (Decrease) in Prepaid Expense
Taysha Gene Therapies, Inc. (TSHA) reported Increase (Decrease) in Prepaid Expense of $604.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2020-11-12
- 2020-09-30: Increase (Decrease) in Prepaid Expense 9 month $604.00K.
- 2019-09-30: Increase (Decrease) in Prepaid Expense 0 month $0.00.
| Period end | Increase (Decrease) in Prepaid Expense 0 month | Increase (Decrease) in Prepaid Expense 9 month |
|---|---|---|
| 2020-09-30 | $604.00K 10-Q · filed 2020-11-12 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |